Document 10Zy3mk5veqQjG6Grk28MznVj

December S, 1074 Mr. F. F. Roasch CT FA Subcammltte Meeting on Asbe&tos fr Talc Tha meeting v/as held at Bristol-Myerse HHtekJo on ftecembsr 4. 1974. Those In aUendanee included; Or, Joseph SImho iMr, Harold Stanley Mr. George SandJanet Mr. George Cohort Mr. Allan Harvey Or, Robert Rolls Or. Georg# Lee Or. John Travers (Cc-Igets) (Pflsar) (Brlste-Myera, Chairman) (B risto l-M yers) (VandfirbUt) <JJ) CJSJ) (Avon) J S J pushed for the commute to submit the attached methods for consideration isy the FDA. This was oppose by most members (Avon and Vanderbilt remained neutral) m tha ground that tha work had bean performed by only Avon and J s J . Reportedly^ Mennw and C^csebrougb-Penda have OTA equipment but they have not started to examine tha samples, Colgate and PR*or have BTA equipment ordered but as yet do not even know; the date of delivery. 1 tojd the group of our OTA work nt Oefeell end Richardson vhara we had 3 samples examined. For our Infomaiion those were identified as: A. #4060 Talc; B, #4665 Tal* C. #609 Talc. Debait and Richardson had reported sample "W5 (W$Q) to contain chrysotHe because It had a paak at 650 degrees C. Dr. M ia felt that thh was not proof of the presence of chrysolite beoause there must be two peak-a (another at 630 degrees C ) . We have agreed to submit another thre blind samples to Dobell 3 Richardson tor additional OTA work. Wo will receive the from Roll (JSJ), It was reported by J&J and also by Avan that the FDA has never Identified ehrysotHo in arty U. S. cosmetic talc. PLAINTIFFS EXHIBIT WCD-199 continued.. . . . . . LoGiudice/WCD/0282 i December 5, T974 Mr, F , F , Reesch CTFA Subcommittee Meeting on Aabe: In Talc f. , Pfizer feels that OTA Is being pu hed by J U because the FDA has similar equipment but they do not have an electron microscope. I fee* that Pfizer Is correct In this attitude but two different types of personnel re involved, it takes much greater skill to operate tha electi on microscope than It does to operate the DTA. ftepomly, the FDA has commissioned the Franklin Institute, Philadelphia to start a research study of asbestos and talc, Tna mm meeting, to bo held at Bristol-Myers, has been tentatively set for Tuesday February 4, 1975, In thfe meantime, Mr, Sandland will try to sat up m InfbrawUonal type meeting with Herman Estrln CTFA}. RRK/mw Ray R. Krammes it'f I I ! LoGiudice/WCD/0283